Innovation Hub
The latest breakthroughs, technologies, and resources across every stage in the drug development lifecycle.
Button Text
.png)
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmacology
In Vitro Assays
Cell Culture & Characterization
BPS Bioscience Inc.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Real-World Data (RWD)
Market Access
No items found.
Blog
Screening the Unscreenable: How Physics-Grounded AI Is Expanding the Reach of Drug Discovery
June 16, 2026
Read blog
Discovery Chemistry
Pharmacology
Protein Sciences
SandboxAQ
Blog
Reducing risk in CRO studies: Choosing the right cell models for outsourced research
June 11, 2026
Read blog
Cell Culture & Characterization
In Vitro Assays
HBS
Toxicology
Pharmacology
PromoCell
Chemistry, Manufacturing & Controls
Raw Materials
DNA & RNA
Landmark Bio
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Ontada
In Vitro Assays
Cell Culture & Characterization
Protein Sciences
DNA & RNA
BPS Bioscience Inc.
Biomarkers
DNA & RNA
Instrumentation & Products
Diagenode
Discovery Chemistry
Protein Sciences
In Vitro Assays
Pharmacology
WuXi AppTec
Blog
AI in HEOR: Three Ways Artificial Intelligence Is Accelerating Evidence Generation
April 23, 2026
Read blog
Health Economics & Outcomes Research (HEOR)
Panalgo, LLC
Blog
AI Is Expanding What's Possible in Drug Discovery. Operational Friction Still Determines How Fast It Happens.
April 17, 2026
Read blog
Pharmacology
No items found.
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Priti Jhingran
Tijana Ignjatovic
Genesis Research Group
HealthEconomics.com
Cell Culture & Characterization
Disease Models
David Barefield
Aurora Scientific, Inc.
American Physiological Society
European Council for Cardiovascular Research
Protein Sciences
Chemical & Compound Analysis
Nayanthara Dharmaratne
Kevin D. Corbett
Wyatt Technology
No items found.
Market Access
Medical Communications
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.
Disease Models
Eliala Alice Salvadori
Jason Rogers
Noldus Information Technology
No items found.
Health Economics & Outcomes Research (HEOR)
Danielle Drachmann
Josie Godfrey
Kristine Sørensen
Beth Lesher
Kelly McCarrier
OPEN Health
HealthEconomics.com
Disease Models
DNA & RNA
Cell Culture & Characterization
Eduardo Marbán
No items found.
American Physiological Society
European Council for Cardiovascular Research
Disease Models
Bradley Palmer
IonOptix
American Physiological Society
European Council for Cardiovascular Research
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Marija Zivkovic-Gojovic
Richard Pitman
Pragya Khurana
ICON
HealthEconomics.com
Disease Models
Ana Briones
Kent Scientific Corporation
American Physiological Society
European Council for Cardiovascular Research
Health Economics & Outcomes Research (HEOR)
No items found.
No items found.
No items found.
Clinical Trials
No items found.
Disease Models
Instrumentation & Products
Discovery Chemistry
Chemical & Compound Analysis
Podcast
#ExpertAnswers: Louise Parr-Brownlie and Conor Underwood on Optogenetic Stimulation
May 10, 2022
Read podcast
Disease Models
Clinical Trials
Disease Models
Podcast
#ExpertAnswers: Joe Soughayer and Adam Veteto on Excitation-Contraction Coupling in Cardiomyocytes
May 4, 2022
Read podcast
Bioimaging
Cell Culture & Characterization
Instrumentation & Products
In Vitro Assays
Pharmacology
Bioimaging
Disease Models
Cell Culture & Characterization
Clinical Trials
HBS
Clinical Trials
Biomarkers
Pharmacology
In Vitro Assays
Disease Models
Medical Communications
Disease Models
Instrumentation & Products
Biometrics
Toxicology
Clinical Trials
No items found.